We hope you find what you’re looking for. You can email us if you need additional help.
We have uploaded the February 13, 2024 webinar to our YouTube channel. To view, please visit the link below: Know Your Psychedelic Drug Candidate: Safeguarding Quality in Psychedelic Therapy
Regulator Filings
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th
